(231 days)
Not Found
No
The description focuses on the mechanical operation of the nebulizer using compressed gas and the Venturi Principle, with no mention of AI or ML.
Yes
The device is intended for the administration of aerosol treatments, primarily FDA-approved drugs for nebulization, which aligns with the purpose of treating a medical condition.
No
Explanation: The device is intended for administering aerosol treatments, which is a therapeutic function, not a diagnostic one. It delivers medication, rather than identifying or monitoring a medical condition.
No
The device description clearly outlines a physical device (nebulizer) that uses compressed gas and the Venturi Principle to aerosolize fluids, indicating it is a hardware-based medical device.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- AMSURE Nebulizer Function: The AMSURE Nebulizer is a device used to administer medication in aerosolized form directly to the patient's respiratory system. It does not perform any tests on bodily samples.
The provided text clearly describes a device for drug delivery, not for diagnostic testing.
N/A
Intended Use / Indications for Use
The AMSURE® Nebulizer is intended for the administration of various aerosol treatments in both the homecare and hospital settings. This device is intended for use only with FDA-approved drugs for nebulization, under the direction of a physician. It can be used for both pediatric and adult patient populations.
Product codes
CAF
Device Description
The AMSure ® Nebulizer is a single-use patient device, which is filled with fluid, typically respiratory medication and connected to a source of compressed via flexible tubing. The nebulizer delivers aerosolized fluids for patient inhalation in the respirable range of approximately 1.0µm to 5.0µm. It operates on a compressed gas source which draws liquids from a refillable cup by the Venturi Principle and aerosolizes it by impaction and baffling.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
pediatric and adult patient populations
Intended User / Care Setting
administration of various aerosol treatments in both the homecare and hospital settings. under the direction of a physician.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance and biocompatibility testing has demonstrated that the AMSure ® Nebulizer is safe and effective for its intended use.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Hudson RCI Micro Mist ® (K930525)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5630 Nebulizer.
(a)
Identification. A nebulizer is a device intended to spray liquids in aerosol form into gases that are delivered directly to the patient for breathing. Heated, ultrasonic, gas, venturi, and refillable nebulizers are included in this generic type of device.(b)
Classification. Class II (performance standards).
0
AMSure® Nebulizer 510(K) Submission
K070411 page 1 of 1
510(K) Summary of Safety and Effectiveness
| Company: | Amsino International, Inc.
855 Towne Center Drive
Pomona, CA 91767
(909) 626-5888 |
|----------------|--------------------------------------------------------------------------------------------|
| Contact: | Ching Ching Seah, Ph.D.
Director of Regulatory Affairs |
| Date Prepared: | August 8, 2007 |
OCT 1 2007
Classification Name: | Nebulizer (Direct Patient Interface) (868.5630) |
---|---|
Common Name: | Nebulizer |
Proprietary Name: | AMSure ® Nebulizer |
Product Code: | CAF |
Medical Specialty: | Anesthesiology |
Device Class: | Class II |
Predicate Devices: | Hudson RCI Micro Mist ® (K930525) |
---|---|
-------------------- | ---------------------------------------------- |
Device Description: | The AMSure ® Nebulizer is a single-use patient device, which is filled with fluid, typically respiratory medication and connected to a source of compressed via flexible tubing. The nebulizer delivers aerosolized fluids for patient inhalation in the respirable range of approximately 1.0µm to 5.0µm. It operates on a compressed gas source which draws liquids from a refillable cup by the Venturi Principle and aerosolizes it by impaction and baffling. |
---|---|
--------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
Intended Use: | The AMSURE ® Nebulizer is intended for the administration of various aerosol treatments in both the homecare and hospital settings. This device is intended for use only with FDA-approved drugs for nebulization, under the direction of a physician. It can be used for both pediatric and adult patient populations. |
---|---|
--------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
Comparison to Predicate: | The AMSure ® Nebulizer is similar to the predicate devices in operational principle, materials, design, technical characteristics and intended use. Any differences do not affect the intended use or the safety and effectiveness of the device. |
---|---|
-------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
Non-Clinical Testing: | Performance and biocompatibility testing has demonstrated that the AMSure ® Nebulizer is safe and effective for its intended use. |
---|---|
----------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------- |
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines representing its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA" is arranged in a circular fashion around the symbol. The text is in all caps and appears to be in a sans-serif font.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Ching Ching Seah, Ph.D. Director of Research, Development and Regulatory Affairs Amsino International, Incorporated 855 Towne Center Drive Pomona, California 91767
OCT 1 2007
Re: K070411
Trade/Device Name: AMSURE® Nebulizer Regulation Number: 21 CFR 868.5630 Regulation Name: Nebulizer Regulatory Class: II Product Code: CAF Dated: September 19, 2007 Received: September 24, 2007
Dear Dr. Seah:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
2
Page 2 - Dr. Seah
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Chiu Lin, Ph.D.
Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(k) Number: (if known) | K070411 |
---|---|
Device Name: | AMSURE® Nebulizer |
Indications for Use: | The AMSURE® Nebulizer is intended for the administration of various aerosol treatments in both the homecare and hospital settings. This device is intended for use only with FDA-approved drugs for nebulization, under the direction of a physician. It can be used for both pediatric and adult patient populations. |
Indications for Use Statement
Prescription Use_ (Per 21 CFR 801. 109) OR
510(k) Number:
Over-The-Counter Use
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED
Concu(Division Sigro Office of Device Evaluation (ODE)
Division of Anesthesiology, General Hospital
Infection Control, Dental Devices